BMO Capital analyst Juan C. Sanabria reiterated an Outperform rating and $67.00 price target on National Health Investors (NYSE: NHI).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE